Arizona Cancer Center Biospecimen Repository

RATIONALE: Collecting and storing samples of tissue and blood from patients with cancer to test in the laboratory may help the study of cancer in the future.

PURPOSE: This research study is collecting and storing tumor, tissue, and blood samples from patients with pancreatic cancer.

Study Overview

• Status: Recruiting
• Conditions: Cancer
• Intervention / Treatment: Other: biologic sample preservation procedure

Detailed Description

OBJECTIVES:

• Provide cancer investigators access to a wide variety of tissues and biospecimens for translational studies in cancer.
• Collect and preserve tissue from the primary organ site (uninvolved and involved with cancer), from the metastases, from patient blood (serum and lymphocytes), and from patient urine.
• Provide quality-controlled storage and management of the specimen bank.
• Collect relevant clinical and pathologic information with appropriate privacy protection.
• Contribute to the development of a comprehensive database annotated with relevant clinical data, pathology, and research findings.

OUTLINE: This is a multicenter study.

Tumor samples, lymph node samples, and normal pancreas tissue samples are collected. Blood samples are also collected prior to surgery, six months after the initial blood draw and tissue sample collection, and every six months thereafter for two years.

• Study Type: Observational
• Enrollment (Estimated): 10000

Contacts and Locations

• Study Contact: Name: Arizona Cancer Center at University of Arizona Health Sciences; Phone Number: 520-626-0950

Study Locations

• United States
  • Arizona
    • Tucson, Arizona, United States, 85724-5024
      • Recruiting
      • Arizona Cancer Center at University of Arizona Health Sciences Center
      • Contact: Setsuko K. Chambers, MD; Phone Number: 866-278-1554

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

The goal of this protocol is to provide cancer investigators access to a wide variety of tissues and biospecimens for translational studies in cancer by collecting and preserving tissue from the primary organ site, from the metastases, from patient blood (serum and lymphocytes), from patient urine, and from related samples of other tissues/fluids removed by the surgeon left over after diagnostic testing. No additional tissue will be taken at the time of surgery other than that required for patient care, but additional blood and urine samples will be obtained at that time. This protocol is not limited to certain types of cancer.

Description

DISEASE CHARACTERISTICS:

• Patient who is seen at the Arizona Cancer Center or University Medical Center and will undergo any surgery or procedure for cancer

PATIENT CHARACTERISTICS:

• NA

PRIOR CONCURRENT THERAPY:

• NA

As this is a biospecimen repository, participation is open to all cancer patients being treated at the Arizona Cancer Center or University Medical Center by investigators on this protocol.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Provision of tissue samples and biospecimens for translational study	An electronic record of the specimens is kept in a secure, web-based database. Follow-up information will be obtained from the patient medical record or from the patient.	July 2024

Collaborators and Investigators

• Sponsor: University of Arizona
• Collaborators: National Cancer Institute (NCI)
• Investigators: Principal Investigator: Setsuko K. Chambers, MD, University of Arizona

Publications and helpful links

Helpful Links

• Clinical trial summary from the National Cancer Institute's PDQ® database

Study record dates

Study Major Dates

• Study Start (Actual): August 1, 2006
• Primary Completion (Estimated): July 1, 2030
• Study Completion (Estimated): July 1, 2030

Study Registration Dates

• First Submitted: May 9, 2009
• First Submitted That Met QC Criteria: May 9, 2009
• First Posted (Estimated): May 12, 2009

Study Record Updates

• Last Update Posted (Actual): April 6, 2026
• Last Update Submitted That Met QC Criteria: March 30, 2026
• Last Verified: March 1, 2026

More Information

Terms related to this study

• Keywords: cancer
• Additional Relevant MeSH Terms: Neoplasms
• Other Study ID Numbers: CDR0000597579; P30CA023074 (U.S. NIH Grant/Contract); UARIZ-06-0609-04 (Other Identifier: University of Arizona); UARIZ-BIO#A06035 (Other Identifier: University of Arizona); UARIZ-SRC18042 (Other Identifier: University of Arizona)